活性双蛋白涂层辅助逐步蛋白-蛋白相互作用组装减少血栓形成和感染
Wentai Zhang1, Jiangling Zhang2, Fangkun Hu2
1Dongguan Key Laboratory of Smart Biomaterials and Regenerative Medicine, The Tenth Affiliated Hospital, Southern Medical University, Dongguan, Guangdong, 523000, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 1, 2024
概括
一种新的逐步蛋白质-蛋白质相互作用组装 (SPPIA) 方法可以为医疗器械制造活性双蛋白涂层. 这种技术保持了蛋白质的功能,减少了凝块的形成和导管上的感染.
科学领域:
- 生物材料科学 生物材料科学
- 表面工程是什么?表面工程是什么?
- 医疗器械涂层 医疗器械涂层
背景情况:
- 通用蛋白质涂层为医疗应用提供生物相容性和易于制造.
- 保持这些涂层中的蛋白质活性仍然是功能设计的一个重大挑战.
研究的目的:
- 开发一种活跃的双蛋白表面工程策略,用于使用简单的逐步蛋白质-蛋白质相互作用组合 (SPPIA) 方法的导管.
- 通过增强的蛋白质涂层功能来减少医疗器械上的凝块形成和感染.
主要方法:
- 该SPPIA方法涉及牛血清白蛋白 (BSA) 和酶 (LZM) 的部分氧化,通过疏水相互作用创建核化平台.
- 无氧化BSA和LZM通过静电相互作用组装到这些平台上,利用它们相反的同电点 (pI).
主要成果:
- 通过SPPIA方法,成功地保持了BSA和LZM的形状和功能.
- 由此产生的蛋白质涂层表现出强大的抗血栓和杀菌性质.
- 涂料表现出粘附性和耐用性,在PBS浸泡中至少15天抵御血栓形成和细菌增殖.
结论:
- SPPIA方法为制造具有功能保留的活性蛋白涂层提供了一个新的策略.
- 这种方法在推进医疗器械,特别是导管的表面工程技术方面显示出重大前景.
相关概念视频
Protein Complex Assembly
10.6K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.6K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Folding
118.1K
Overview
118.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Coat Assembly and GTPases
3.5K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
3.5K


